Text

Ejournal PSKM : Monitoring Kidney Function Through The Use Of Candesartan Telmisartan Or Valsartan Antihypertensive Therapy Towards Patients CKD

---

Chronic Kidney Disease (CKD) lower kidney function caused by an irreversible reduction in normal nephron function. Globally, CKD contributes to the cause of death. Activation of the Renin-Angiotensin-Aldosteronesystem is involved in the pathogenesis. ARBshave a cardiorenal protective effect. The purpose of this study was to determine the changes in kidney function with the use of Candesartan, Telmisartan or Valsartan antihypertensive therapies in CKD patients. This research method was a prospec-tive observational cohort study looking at changes in kidney function (BUN and Serum Creatinine) at 1 and 6 months of using Antihypertensive Drugs Valsartan, Telmisartan, and Candesar-tan and tested by statistical analysis. The number of samples in this study was 72 patients which are 24 patients (Candesartan), 27 patients (Telmisartan), and 21 patients (Valsartan). The re-sults showed that the Candesartan group experienced a de-crease in average BUN of 0.13±0.85 mg/dl and serum creatinine of 0.004±0.09 mg/dl with independent t-test p=0.479 (p>0.05), Serum Creatinine p= 0.809 (p>0.05). The Telmisartan group ex-perienced a decrease in average BUN of 4.74±5.16 mg/dl and se-rum creatinine of 0.33±0.20 mg/dl with Wilcoxon BUN test re-sults p=0.000 (p

---

Ketersediaan

MKMI001

610 SEL m

My Library

Tersedia

Informasi Detail

Judul Seri

-

No. Panggil

610 SEL m

Penerbit

Makassar : Universitas Hasanuddin., 2022

Deskripsi Fisik

-

Bahasa

English

ISBN/ISSN

2356-4067

Klasifikasi

610

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

Vol. 18 No 1

Subjek

-

Info Detail Spesifik

-

Pernyataan Tanggungjawab

-

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus login sebelum memberikan komentar